Quanterix appoints diagnostics veteran Brian Blaser to Board of Directors

Quanterix Corp

Brian Blaser appointed to Quanterix board effective Jan 6, 2023 as Class III director term expiring at 2023 annual meeting.
Blaser brings 25+ years in diagnostics, including 15 at Abbott leading global diagnostics and the Alere acquisition.
Received equity award valued at $400K: 60% non-qualified stock options and 40% RSUs, vesting over 3 years.
No family relationships or material interests in transactions with the company.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Brian J. Blaser

Director

QTRX · Quanterix Corp

Effective: 2023-01-06
Filed: January 9, 2023, 6:59 PM ET

On January 6, 2023, the board of directors (the “Board”) of Quanterix Corporation (the “Company”) appointed Brian J. Blaser to serve on the Board effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brian J. Blaser was appointed as Director at Quanterix Corp.

Action: appointed
Role: Director

Exact text from the filing

On January 6, 2023, the board of directors (the “Board”) of Quanterix Corporation (the “Company”) appointed Brian J. Blaser to serve on the Board effective immediately.

View on SEC.gov

Quanterix Corp filing history →

Source: SEC EDGAR

accession 0001104659-23-002296

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.